Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the beginning of 2018. Several of the CTS client forms specify list the Medical Director in the header and these forms will be updated on March 5, 2018. Check out the Communication page for a complete list of forms or by clicking the link below: Communications
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...